The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Two Decades After BRCA: Setting Paradigms in Personalized Cancer Care and Prevention
Open accessAbstract
The cloning of the breast cancer susceptibility genes BRCA1 and BRCA2 nearly two decades ago helped set in motion an avalanche of research exploring how genomic information can be optimally applied to identify and clinically care for individuals with a high risk of developing cancer. Genetic testing for mutations in BRCA1 , BRCA2 , and other breast cancer susceptibility genes has since proved to be a valuable tool for determining eligibility for enhanced screening and prevention strategies, as well as for identifying patients most likely to benefit from a targeted therapy. Here, we discuss the landscape of inherited mutations and sequence variants in BRCA1 and BRCA2 , the complexities of determining disease risk when the pathogenicity of sequence variants is uncertain, and current strategies for clinical management of women who carry BRCA1/2 mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802
Kriege, M., Brekelmans, C. T. M., Boetes, C., Besnard, P. E., Zonderland, H. M., Obdeijn, I. M., Manoliu, R. A., Kok, T., Peterse, H., Tilanus-Linthorst, M. M. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031759 · Cited by 1,687
Domchek, S. M. (2010) · JAMA · doi:10.1001/jama.2010.1237 · Cited by 1,494
Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations
Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., van't Veer, L., Garber, J. E., Evans, G., Isaacs, C., Daly, M. B., Matloff, E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012158 · Cited by 1,465
Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation
Kauff, N. D., Satagopan, J. M., Robson, M. E., Scheuer, L., Hensley, M., Hudis, C. A., Ellis, N. A., Boyd, J., Borgen, P. I., Barakat, R. R., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020119 · Cited by 1,251
Self-citationBRCA1 Mutations in Primary Breast and Ovarian Carcinomas
Futreal, P. A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L. M., Haugen-Strano, A., Swensen, J., Miki, Y., et al. (1994) · Science · doi:10.1126/science.7939630 · Cited by 1,205
Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van ’t Veer, L., Garber, J. E., Evans, G. R., Narod, S. A., Isaacs, C., Matloff, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.188 · Cited by 1,171
Kuhl, C. K., Schrading, S., Leutner, C. C., Morakkabati-Spitz, N., Wardelmann, E., Fimmers, R., Kuhn, W., & Schild, H. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.4960 · Cited by 1,147
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
The Breast and Ovarian Cancer Susceptibility Collaboration, Michailidou, K., Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), kConFab Investigators, Australian Ovarian Cancer Study Group, The GENICA (Gene Environment Interaction and Breast Cancer in Germany) Network, Hall, P., Gonzalez-Neira, A., Ghoussaini, M., Dennis, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2563 · Cited by 1,069
Self-citationPennington, K. P., Walsh, T., Harrell, M. I., Lee, M. K., Pennil, C. C., Rendi, M. H., Thornton, A., Norquist, B. M., Casadei, S., Nord, A. S., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2287 · Cited by 1,051
Resistance to therapy caused by intragenic deletion in BRCA2
Edwards, S. L., Brough, R., Lord, C. J., Natrajan, R., Vatcheva, R., Levine, D. A., Boyd, J., Reis-Filho, J. S., & Ashworth, A. (2008) · Nature · doi:10.1038/nature06548 · Cited by 1,011
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
The Breast Cancer Susceptibility Collaboration (UK), Rahman, N., Seal, S., Thompson, D., Kelly, P., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., et al. (2007) · Nature Genetics · doi:10.1038/ng1959 · Cited by 1,003
Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients With Early-Onset Breast Cancer
Peto, J., Collins, N., Barfoot, R., Seal, S., Warren, W., Rahman, N., Easton, D. F., Evans, C., Deacon, J., & Stratton, M. R. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.943 · Cited by 873
Frequency and Spectrum of Cancers in the Peutz-Jeghers Syndrome
Hearle, N., Schumacher, V., Menko, F. H., Olschwang, S., Boardman, L. A., Gille, J. J. P., Keller, J. J., Westerman, A. M., Scott, R. J., Lim, W., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0083 · Cited by 855
Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
Roa, B. B., Boyd, A. A., Volcik, K., & Richards, C. S. (1996) · Nature Genetics · doi:10.1038/ng1096-185 · Cited by 770
Oral Contraceptives and the Risk of Hereditary Ovarian Cancer
Narod, S. A., Risch, H., Moslehi, R., Dørum, A., Neuhausen, S., Olsson, H., Provencher, D., Radice, P., Evans, G., Bishop, S., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808133390702 · Cited by 615
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
Antoniou, A. C., Cunningham, A. P., Peto, J., Evans, D. G., Lalloo, F., Narod, S. A., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Southey, M. C., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604305 · Cited by 525
Gayther, S. A., Warren, W., Mazoyer, S., Russell, P. A., Harrington, P. A., Chiano, M., Seal, S., Hamoudi, R., van Rensburg, E. J., Dunning, A. M., et al. (1995) · Nature Genetics · doi:10.1038/ng1295-428 · Cited by 496
Variation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers
Thompson, D., & Easton, D. (2001) · The American Journal of Human Genetics · doi:10.1086/318181 · Cited by 489
Mechanisms of resistance to therapies targeting BRCA-mutant cancers
Lord, C. J., & Ashworth, A. (2013) · Nature Medicine · doi:10.1038/nm.3369 · Cited by 449
Eisen, A., Lubinski, J., Klijn, J., Moller, P., Lynch, H. T., Offit, K., Weber, B., Rebbeck, T., Neuhausen, S. L., Ghadirian, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.7138 · Cited by 443
Self-citationBRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients
Petrij-Bosch, A., Peelen, T., van Vliet, M., Eijk, R. V., Olmer, R., Drüsedau, M., Hogervorst, F. B. L., Hageman, S., Arts, P. J. W., Ligtenberg, M. J. L., et al. (1997) · Nature Genetics · doi:10.1038/ng1197-341 · Cited by 432
Performance of Common Genetic Variants in Breast-Cancer Risk Models
Wacholder, S., Hartge, P., Prentice, R., Garcia-Closas, M., Feigelson, H. S., Diver, W. R., Thun, M. J., Cox, D. G., Hankinson, S. E., Kraft, P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907727 · Cited by 411
Genome-wide association studies identify four ER negative–specific breast cancer risk loci
The Gene ENvironmental Interaction and breast CAncer (GENICA) Network, Garcia-Closas, M., kConFab Investigators, (FBCS), F. B. C. S., Australian Breast Cancer Tissue Bank (ABCTB) Investigators, Couch, F. J., Lindstrom, S., Michailidou, K., Schmidt, M. K., Brook, M. N., et al. (2013) · Nature Genetics · doi:10.1038/ng.2561 · Cited by 406
Self-citationScreening women at high risk for breast cancer with mammography and magnetic resonance imaging
Lehman, C. D., Blume, J. D., Weatherall, P., Thickman, D., Hylton, N., Warner, E., Pisano, E., Schnitt, S. J., Gatsonis, C., Schnall, M., et al. (2005) · Cancer · doi:10.1002/cncr.20971 · Cited by 401
Goldgar, D. E., Easton, D. F., Deffenbaugh, A. M., Monteiro, A. N. A., Tavtigian, S. V., & Couch, F. J. (2004) · The American Journal of Human Genetics · doi:10.1086/424388 · Cited by 391
Self-citationMutations in the BRCA1 gene in families with early-onset breast and ovarian cancer
Castilla, L. H., Couch, F. J., Erdos, M. R., Hoskins, K. F., Calzone, K., Garber, J. E., Boyd, J., Lubin, M. B., Deshano, M. L., Brody, L. C., et al. (1994) · Nature Genetics · doi:10.1038/ng1294-387 · Cited by 383
Self-citationOddoux, C., Struewing, J. P., Clayton, C. M., Neuhausen, S., Brody, L. C., Kaback, M., Haas, B., Norton, L., Borgen, P., Jhanwar, S., et al. (1996) · Nature Genetics · doi:10.1038/ng1096-188 · Cited by 381
Self-citationOral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
Narod, S. A. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.23.1773 · Cited by 380
High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome
Bubien, V., Bonnet, F., Brouste, V., Hoppe, S., Barouk-Simonet, E., David, A., Edery, P., Bottani, A., Layet, V., Caron, O., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101339 · Cited by 376
Genetic susceptibility to breast cancer
Mavaddat, N., Antoniou, A. C., Easton, D. F., & Garcia-Closas, M. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.04.011 · Cited by 375
Couch, F. J., Wang, X., McGuffog, L., Lee, A., Olswold, C., Kuchenbaecker, K. B., Soucy, P., Fredericksen, Z., Barrowdale, D., Dennis, J., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003212 · Cited by 371
Self-citationMetcalfe, K. A., Birenbaum‐Carmeli, D., Lubinski, J., Gronwald, J., Lynch, H., Moller, P., Ghadirian, P., Foulkes, W. D., Klijn, J., Friedman, E., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23340 · Cited by 342
Self-citationSardanelli, F., Podo, F., D'Agnolo, G., Verdecchia, A., Santaquilani, M., Musumeci, R., Trecate, G., Manoukian, S., Morassut, S., de Giacomi, C., et al. (2007) · Radiology · doi:10.1148/radiol.2423051965 · Cited by 339
The Gene Environment Interaction and Breast Cancer in Germany (GENICA) Consortium, Haiman, C. A., Chen, G. K., Vachon, C. M., Canzian, F., Dunning, A., Millikan, R. C., Wang, X., Ademuyiwa, F., Ahmed, S., et al. (2011) · Nature Genetics · doi:10.1038/ng.985 · Cited by 306
Self-citationBRCA1 RING Function Is Essential for Tumor Suppression but Dispensable for Therapy Resistance
Drost, R., Bouwman, P., Rottenberg, S., Boon, U., Schut, E., Klarenbeek, S., Klijn, C., van der Heijden, I., van der Gulden, H., Wientjens, E., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.014 · Cited by 262
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: An update
Gronwald, J., Tung, N., Foulkes, W. D., Offit, K., Gershoni, R., Daly, M., Kim‐Sing, C., Olsson, H., Ainsworth, P., Eisen, A., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21536 · Cited by 254
Self-citationGermline RAD51C mutations confer susceptibility to ovarian cancer
Breast Cancer Susceptibility Collaboration (BCSC) (UK), Loveday, C., Turnbull, C., Ruark, E., Xicola, R. M. M., Ramsay, E., Hughes, D., Warren-Perry, M., Snape, K., Eccles, D., et al. (2012) · Nature Genetics · doi:10.1038/ng.2224 · Cited by 252
Management of an Inherited Predisposition to Breast Cancer
Robson, M., & Offit, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp071286 · Cited by 252
Self-citationMcLaughlin, J. R., Risch, H. A., Lubinski, J., Moller, P., Ghadirian, P., Lynch, H., Karlan, B., Fishman, D., Rosen, B., Neuhausen, S. L., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70983-4 · Cited by 247
Self-citationMultiplex Genetic Testing for Cancer Susceptibility: Out on the High Wire Without a Net?
Domchek, S. M., Bradbury, A., Garber, J. E., Offit, K., & Robson, M. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.9403 · Cited by 237
Self-citationLindor, N. M., Guidugli, L., Wang, X., Vallée, M. P., Monteiro, A. N. A., Tavtigian, S., Goldgar, D. E., & Couch, F. J. (2012) · Human Mutation · doi:10.1002/humu.21627 · Cited by 235
Self-citationTavtigian, S. V., Byrnes, G. B., Goldgar, D. E., & Thomas, A. (2008) · Human Mutation · doi:10.1002/humu.20896 · Cited by 227
Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155
Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Chang, S., Wang, R.-H., Akagi, K., Kim, K.-A., Martin, B. K., Cavallone, L., Haines, D. C., Basik, M., Mai, P., et al. (2011) · Nature Medicine · doi:10.1038/nm.2459 · Cited by 224
Collett, K., Stefansson, I. M., Eide, J., Braaten, A., Wang, H., Eide, G. E., Thoresen, S. Ø., Foulkes, W. D., & Akslen, L. A. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0394 · Cited by 215
French, J. D., Ghoussaini, M., Edwards, S. L., Meyer, K. B., Michailidou, K., Ahmed, S., Khan, S., Maranian, M. J., O’Reilly, M., Hillman, K. M., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.01.002 · Cited by 207
Self-citationPersonalized medicine: new genomics, old lessons
Offit, K. (2011) · Human Genetics · doi:10.1007/s00439-011-1028-3 · Cited by 203
Self-citationOlivier, R. I., Lubsen-Brandsma, M. A. C., Verhoef, S., & van Beurden, M. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.08.038 · Cited by 180
Antoniou, A. C., Beesley, J., McGuffog, L., Sinilnikova, O. M., Healey, S., Neuhausen, S. L., Ding, Y. C., Rebbeck, T. R., Weitzel, J. N., Lynch, H. T., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1907 · Cited by 176
Self-citationLee, M. S., Green, R., Marsillac, S. M., Coquelle, N., Williams, R. S., Yeung, T., Foo, D., Hau, D. D., Hui, B., Monteiro, A. N. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4563 · Cited by 168
Weitzel, J. N., Clague, J., Martir-Negron, A. E., Ogaz, R., Herzog, J., Ricker, C. N., Jungbluth, C. R., Cina, C., Duncan, P. R., Unzeitig, G. W., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0027 · Cited by 168
Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer
Gaudet, M. M., Kirchhoff, T., Green, T., Vijai, J., Korn, J. M., Guiducci, C., Segrè, A. V., McGee, K., McGuffog, L., Kartsonaki, C., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001183 · Cited by 162
Self-citationPurrington, K. S., Slager, S., Eccles, D., Yannoukakos, D., Fasching, P. A., Miron, P., Carpenter, J., Chang-Claude, J., Martin, N. G., Montgomery, G. W., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt404 · Cited by 161
Self-citationCancer Genomics and Inherited Risk
Stadler, Z. K., Schrader, K. A., Vijai, J., Robson, M. E., & Offit, K. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.7271 · Cited by 159
Self-citationHermsen, B. B. J., Olivier, R. I., Verheijen, R. H. M., van Beurden, M., de Hullu, J. A., Massuger, L. F. A. G., Burger, C. W., Brekelmans, C. T. M., Mourits, M. J. E., de Bock, G. H., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603725 · Cited by 155
Huizing, M., Iacobazzi, V., IJlst, L., Savelkoul, P. J. M., Ruitenbeek, W., van den Heuvel, L., Indiveri, C., Smeitink, J. A. M., Trijbels, F. J. M., Wanders, R. J. A., et al. (1997) · The American Journal of Human Genetics · doi:10.1086/301628 · Cited by 151
A High-Throughput Functional Complementation Assay for Classification of BRCA1 Missense Variants
Bouwman, P., van der Gulden, H., van der Heijden, I., Drost, R., Klijn, C. N., Prasetyanti, P., Pieterse, M., Wientjens, E., Seibler, J., Hogervorst, F. B. L., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0094 · Cited by 140
Clinical significance of large rearrangements in BRCA1 and BRCA2
Judkins, T., Rosenthal, E., Arnell, C., Burbidge, L. A., Geary, W., Barrus, T., Schoenberger, J., Trost, J. T., WENSTRUP, R. J., & Roa, B. B. (2012) · Cancer · doi:10.1002/cncr.27556 · Cited by 134
Functional Assays for Analysis of Variants of Uncertain Significance inBRCA2
Guidugli, L., Carreira, A., Caputo, S. M., Ehlén, Å., Galli, A., Monteiro, Á. N. A., Neuhausen, S. L., Hansen, T. V. O., Couch, F. J., & Vreeswijk, M. P. G. (2013) · Human Mutation · doi:10.1002/humu.22478 · Cited by 132
Self-citationGuidugli, L., Pankratz, V. S., Singh, N., Thompson, J. E., Erding, C. A., Engel, C., Schmutzler, R. K., Domchek, S. M., Nathanson, K. L., Radice, P., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2081 · Cited by 125
Self-citationBRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 50
Haile, R. W., Thomas, D. C., McGuire, V. M., Felberg, A., John, E. M., Milne, R. L., Hopper, J. L., Jenkins, M. A., Levine, A. J., Daly, M. M., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0258 · Cited by 123
Spurdle, A. B., Whiley, P. J., Thompson, B. A., Feng, B., Healey, S. C., Brown, M. A., Pettigrew, C. A., kConFab, van Asperen, C. J., Ausems, M. G. E. M., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101037 · Cited by 123
Self-citationLorenzo, S. B. D., Patel, A. G., Hurley, R. M., & Kaufmann, S. H. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00228 · Cited by 117
Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk
Gaudet, M. M., Kuchenbaecker, K. B., Vijai, J., Klein, R. J., Kirchhoff, T., McGuffog, L., Barrowdale, D., Dunning, A. M., Lee, A., Dennis, J., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003173 · Cited by 111
Self-citationMeyer, K. B., O’Reilly, M., Michailidou, K., Carlebur, S., Edwards, S. L., French, J. D., Prathalingham, R., Dennis, J., Bolla, M. K., Wang, Q., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.10.026 · Cited by 106
19p13.1 Is a Triple-Negative–Specific Breast Cancer Susceptibility Locus
Stevens, K. N., Fredericksen, Z., Vachon, C. M., Wang, X., Margolin, S., Lindblom, A., Nevanlinna, H. A., Greco, D., Aittomäki, K., BLOMQVIST, C. P., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3364 · Cited by 105
King, M. (2014) · Science · doi:10.1126/science.1251900 · Cited by 101
PARP inhibitors for anticancer therapy
Curtin, N. J. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130187 · Cited by 91
A Role for Common Genomic Variants in the Assessment of Familial Breast Cancer
Sawyer, S. D., Mitchell, G., McKinley, J. M., Chenevix‐Trench, G., Beesley, J., Chen, X. Q., Bowtell, D. D. L., Trainer, A. H., Harris, M., Lindeman, G. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.7469 · Cited by 84
Wang, X., Pankratz, V. S., Fredericksen, Z., Tarrell, R. F., Karaus, M., McGuffog, L., Pharaoh, P. D. P., Ponder, B. A. J., Dunning, A. M., Peock, S., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq174 · Cited by 77
Self-citationBiswas, K., Das, R., Eggington, J. M., Qiao, H., North, S. L., Stauffer, S., Burkett, S. S., Martin, B. K., Southon, E. A., Sizemore, S., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds222 · Cited by 77
Common breast cancer risk variants in the post-COGS era: a comprehensive review
Maxwell, K. N., & Nathanson, K. L. (2013) · Breast Cancer Research · doi:10.1186/bcr3591 · Cited by 76
Self-citationAntoniou, A. C., Kartsonaki, C., Sinilnikova, O. M., Soucy, P., McGuffog, L., Healey, S. C., Lee, A., Peterlongo, P., Manoukian, S., Peissel, B., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr226 · Cited by 74
Self-citationRevealing the Incidentalome When Targeting the Tumor Genome
Bombard, Y., Robson, M. E., & Offit, K. (2013) · JAMA · doi:10.1001/jama.2013.276573 · Cited by 68
Self-citationModification ofBRCA1-Associated Breast and Ovarian Cancer Risk byBRCA1-Interacting Genes
Rebbeck, T. R., Mitra, N., Domchek, S. M., Wan, F., Friebel, T. M., Tran, T. V., Singer, C. F., Tea, M.-K. M., Blum, J. L., Tung, N., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0773 · Cited by 68
Self-citationIversen, E. S., Couch, F. J., Goldgar, D. E., Tavtigian, S. V., & Monteiro, Á. N. A. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-1214 · Cited by 62
Self-citationHall, A., Chowdhury, S., Hallowell, N., Pashayan, N., Dent, T., Pharoah, P. D. P., & Burton, H. (2013) · Journal of Public Health · doi:10.1093/pubmed/fdt078 · Cited by 60
BRCA Mutation Frequency and Penetrance: New Data, Old Debate
Offit, K. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj500 · Cited by 48
Self-citationGenome-wide Association Studies of Cancer Predisposition
Stadler, Z. K., Vijai, J., Thom, P., Kirchhoff, T., Hansen, N. A. L., Kauff, N. D., Robson, M. E., & Offit, K. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.06.009 · Cited by 45
Self-citationPublic health genomics and personalized prevention: lessons from the COGS project
Pashayan, N., Hall, A., Chowdhury, S., Dent, T., Pharoah, P. D. P., & Burton, H. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12094 · Cited by 29
Cited by
Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., Liu, W., Huang, B., Luo, W., et al. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.001 · Cited by 1,486
Lord, C. J., & Ashworth, A. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.21 · Cited by 1,257
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
Davies, H., Glodzik, D., Morganella, S., Yates, L. R., Staaf, J., Zou, X., Ramakrishna, M., Martin, S., Boyault, S., Sieuwerts, A. M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4292 · Cited by 1,086
Synthetic Lethality and Cancer Therapy: Lessons Learned from the Development of PARP Inhibitors
Lord, C. J., Tutt, A. N. J., & Ashworth, A. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-050913-022545 · Cited by 471
Kamińska, M., Ciszewski, T., Łopacka-Szatan, K., Miotła, P., & Starosławska, E. (2015) · Menopausal Review · doi:10.5114/pm.2015.54346 · Cited by 383
Metadata
- Authors
- Couch, F. J., Nathanson, K. L., & Offit, K.
- Venue
- Science
- Published
- 2014-03-28
- Volume
- 343
- Issue
- 6178
- Pages
- 1466-1470
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2162956417
- Cited by
- 342
- References
- 89
- FWCI
- 25.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.